Beta Interferons and Glatiramer Acetate for Treatment of MS: TA Guidance 2018

Progress in Neurology and Psychiatry - United Kingdom
doi 10.1002/pnp.504
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search